Company Filing History:
Years Active: 2022
Title: Laura M Seestaller-Wehr: Innovator in Multiple Myeloma Prognosis
Introduction
Laura M Seestaller-Wehr is a notable inventor based in Collegeville, PA (US). She has made significant contributions to the field of medical research, particularly in the prognosis and treatment of multiple myeloma. Her innovative work has led to the development of methods that enhance patient care and treatment outcomes.
Latest Patents
Laura holds a patent for a prognostic method that determines the prognosis of multiple myeloma in patients by measuring the expression of BCMA in a sample. This patent also includes methods for treating multiple myeloma by administering an effective amount of an antigen-binding protein that binds BCMA. Additionally, she has developed kits for measuring BCMA expression in samples, which are crucial for effective diagnosis and treatment.
Career Highlights
Laura is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where she continues to advance her research and innovations. Her work is instrumental in bridging the gap between scientific research and practical applications in the medical field.
Collaborations
Laura has collaborated with esteemed colleagues, including Danton Bounds and Jenny L Craigen, to further her research initiatives. These collaborations have enriched her work and contributed to the development of effective treatment methodologies.
Conclusion
Laura M Seestaller-Wehr is a pioneering inventor whose work in multiple myeloma prognosis and treatment is making a significant impact in the medical community. Her innovative methods and dedication to research exemplify the importance of advancements in healthcare.